In Escherichia coli K-12, amplifiable resistance to tetracycline, chloramphenicol, and other unrelated antibiotics was mediated by at least four spatially separated loci. Tetracycline-sensitive mutants were isolated by TnS insertional inactivation of an amplified multiply resistant strain. One of these, studied in detail, showed coordinate loss of expression of all other resistance phenotypes. The Tn5 element in this mutant mapped to 34 min on the E. coli K-12 linkage map. We have designated the locus marA (multiple antibiotic resistance). Tetracyclinesensitive mutants containing marA::TnS regained all resistance phenotypes at frequencies of 10-8 to 10-upon precise excision of TnS. Moreover, a newly described tetracycline efflux system (A. M. George and S. B. Levy, J. Bacteriol. 155:531-540, 1983) was inactivated in tetracycline-sensitive mutants, but recovered in tetracycline-resistant revertants. In merodiploids, F-prime marA+ expressed partial or complete dominance over corresponding mutant chromosomal alleles. Dominance tests also established that a previously amplified host and a mutant marA allele were preconditions for the expression of phenotypic resistances.
In the accompanying paper (9), we have described high-level resistance to tetracycline, chloramphenicol, and other antibiotics in plasmidless strains of Escherichia coli. Initially, spontaneous Tet and Cml mutants were isolated by selection on complex agar medium containing either drug at 5 ,ug/ml. These low-level resistance mutants were then "amplified" to highlevel resistance (>100 ,ug/ml) either by stepwise transfer of clones on plates containing incrementally higher concentrations of tetracycline or chloramphenicol or by growth for many generations in liquid medium containing tetracycline or chloramphenicol at 5 ,ug/ml. Amplification of resistance by tetracycline or chloramphenicol selection resulted in coincident resistance to a number of other antibiotics (9) . In the absence of drug selection, resistance reverted to low levels within 100 generations.
We present evidence here for involvement of four regions of the E. coli K-12 chromosome in this resistance. The isolation of tetracyclinesensitive mutants by the insertion of TnS into a single locus, which mapped in the major cotransduction gap of the E. coli K-12 chromosome, allowed identification of the marA locus (for multiple antibiotic resistance). marA is essential for the expression of all the emergent chromosomal resistance phenotypes and the tetracycline efflux system (9) .
MATERIALS AND METHODS
Bacteril strai. All strains were E. coli K-12 (Table   1 or listed below).
Media. MacConkey lactose, L, and minimal A liquid or agar media supplemented with antibiotics, amino acids, or other requirements were prepared as described elsewhere (9) .
Selction of Tet and Cml mutants and amplification of resistan. The methods employed for the selection and amplification of resistance phenotypes and minimum inhibitory concentrations (MICs) are described in the accompanying paper (9) .
P1 transductions. The use of P1 vir for generalized transduction has been described previously (6, 11 (9) .
After infection, washing, and aeration at 30°C for 90 min, enrichment for tetracycline-sensitive cells by two cycles of D-cycloserine treatment (11) in the presence of tetracycline (5 p.g/ml) was carried out. Samples were spread over MacConkey agar plates containing kanamycin at 30 ,g/ml, and the plates were incubated for 24 to 36 h at 37°C. Kanamycin-resistant clones were purified on master plates containing kanamycin and replica-plated to plates containing tetracycline or chloramphenicol at 5 or 10 ,g/ml. To distinguish between tetracycline-sensitive back-mutants and TnS insertional tetracycline-sensitive mutants, we examined the level of Tcr in AG102 after growth in the absence of tetracycline for the same number of generations as the transfected culture; 5,000 of 5,000 tested AG102 clones retained resistance to tetracycline at 10 FLg/ml (Tc10f).
Mating experiments. Time of entry and gradient of transfer matings were performed between Hfr and Fstrains as described previously (6, 10) . Resistant donors and recipients were constructed by selection and amplification before matings. In the time of entry matings, recombinants were selected on amino acidsupplemented minimal agar plates that were then replica-plated to antibiotic-supplemented agar plates. Hfr strains were obtained from the E. coli Genetic Stock Center (B. Bachmann, Curator); their origins of transfer are given in reference 2. Conjugal transfers of plasmids with appropriate selection and counterselection were performed as described previously (6, 11) .
Tetracycline transport assays. Tetracycline transport assays were performed as described in the accompanying paper (9) .
Definitions. Amplification of resistance and phenotypic designations are defined in the accompanying paper (9) . Tet and Cml denote mutants selected by tetracycline and chloramphenicol, but these mutants elaborate cross-resistance to many antibiotics (9) . RESULTS Mapping of resistance regions. To determine whether selection and amplification of Tet and Cml mutants and the attendant multiple resistance phenotypes were derived from chromosomal mutation(s), we mapped Tcr and Cmr by Hfr gradient of transfer and F' plasmid dominance.
(i) Transfer of resistance phenotypes. Two types of experiments were performed. In the first, Hfr donors (KL96, B8, and U7) were amplified to high-level Tcr or Cmr and then mated with PA309. In a second series of matings, sensitive Hfr donors were crossed with tetracycline-or chloramphenicol-amplified recipients. In neither type of experiment was highlevel Tcr or Cmr totally transferred or lost, even after very long matings. Without exception, we could only obtain transfer of about 25% of the Tcr or Cmr levels originally expressed in the donors. The transconjugant resistance phenotypes consistently mapped between trp and his, regardless of the origin of transfer of the donor Hfr strain. In Cml mutants only, a second locus mediating Cmr mapped between gal and trp, and we assumed this to be the cmlA mutation (13, 14) .
In time of entry matings spanning the trp-his region, Tcr was not expressed in transconjugants after mating a resistant donor (KL96 amplified with tetracycline or chloramphenicol) with a sensitive recipient (PA309). This failure to locate Tcr in the trp-his region was an unexpected result since the gradient of transfer matings had consistently mapped the gene for Tcr to this region. Our interpretation was that Tcr might require the cooperation ofwell-dispersed alleles.
(ii) Mapping by F' plasmid dominance. Transacting wild-type episomes (F13, F112, F123, F126, F500, F506, and F621) expressed partial dominance to corresponding regions of tetracycline-or chloramphenicol-amplified mutant chromosomes (Table 2 ). These tests define Tcr Although these mapping data do not localize discrete resistance alleles, they do support a multigenic model of chromosomal tetracycline and chloramphenicol resistances.
Identfication of a resistance locus by insertional inactivation. AG102 (TclOr; a second-step Tet mutant) was mutagenized with TnS using a A ::TnS vector, and Kmr clones were isolated. Ten thousand Kmr transductants were screened for Tc5 and Cms. Of these, three were completely sensitive to tetracycline and choramphenicol, and 7 were less resistant to tetracycline or choramphenicol or both. All 10 mutants elaborated mucoid phenotypes on complex agar at 37°C. One of the tetracycline-sensitive mutants, designated AG1025, was selected for further analysis. AG1025 expressed greater sensitivity to tetracycline and chloramphenicol than even the original parent, AG100 (Table 3) . Random and directed Tn5 insertions into AG100 (strains AG1004 and AG1005 in Table 3 ) did not alter the MICs for tetracycline, minocycline, and chloramphenicol or produce mucoidy.
AG1025 did not exhibit the tetracycline efflux system seen in the tetracycline-resistant parent, AG102 (9) . Moreover, AG1025 showed an active uptake of tetracycline that was nearly twice that of the sensitive AG100 strain (data not shown). This result was consistent with the lower MIC of tetracycline in AG1025 compared with that in AG100 (Table 3) . Strain AG1025 had regained sensitivity to all other antibiotics (nalidixic acid, rifampicin, puromycin, penicillin G, ampicillin, cephalothin, and minocycline) toward which AG102 showed resistance (9) .
A reversion test, designed to select Tet rever- 6 were leu+, and 1 was argH+). More precise mapping by interrupted matings located the TnS insertion near the midpoint (34 to 35 min) of the trp-his region. Next, we attempted to determine P1 cotransductional linkage of TnS to known markers in the midrange of the trp-his region (Table  4) . TnS and manA were 1.4 to 1.7% cotransducible, which represents a map distance of 1.6 min apart (17) . TnS and ksgB were not cotransducible. The ksgB locus has been recently repositioned (7) to min 36.5 on the clockwise side of manA. This datum enabled us to position the TnS site on the counterclockwise side of manA, near relB at the edge of the major cotransduction gap.
Recently, the major cotransduction gap has been spanned by the insertion and mapping of various transposons in a "leapfrog" pattern (3, 8) . We utilized one of these new strains, PLK1253, which contains TnlO and Tn9 insertions near the TnS-inactivated locus. With AG1025 as the P1 donor strain and PLK1253 as the recipient, TnlO and Tn9 were crossed out at frequencies of 55 and 18%, respectively. In the reciprocal cross with PLK1253 as the donor, TnS was crossed out of AG1025 at frequencies of 53% by TnlO and 6% by Tn9. These data indicated that TnS was much closer to TnlO at min 34.2 than to Tn9 at min 33.3. The transductions described above were used to construct strains containing all three transposons; with a manA recipient (GMS407), a series of two-factor crosses were performed (Table 4) . TnS and TnlO were cotransduced at frequencies of 68 to 89o, depending upon the donor strains used and whether Kmr or Tcr was the selected phenotype. When all of the crosses listed were considered, the data were consistent with the map order of genes and transposon insertions given in Fig. 1 . The TnS insertion was placed at min 34.05 just inside the major cotransduction gap. We have designated the new locus marA (multiple antibiotic resistance).
The TnS-inactivating insertions of the other two originally isolated tetracycline-sensitive mutants of AG102 also mapped in the marA locus, but we cannot determine whether these were independent insertion mutants. (Table 5) .
marA lou affects the expression of highlevel Tcr and Cmr. Representative K-12 strains were amplified to high levels (50 to 100 ILg/ml) of Tcr and Cmr by selection in the presence of either drug. These mutants were then transduced to Km' with P1 * AG1025 and the purified transductants were scored for Tc' and Cm' (Table 6) . Nontransduced, amplified strains were included as controls to monitor maximum residual Tcr and Cmr. These were found to be reduced by less than 10%o of the amplified levels.
When the selection and amplification was with tetracycline, 93 to 99% of clones selected for Kmr were sensitive to tetracycline and chloramphenicol (Table 6 ), even though the recipients were resistant to drug concentrations up to 10-fold higher than was the original strain, AG102, from which the Pl-inactivating lysate was derived. When the selection and amplification was with chloramphenicol, two results were obtained. In some cases, 98 to 99%o of Kmr transductants were sensitive to tetracycline and chloramphenicol, as seen with tetracycline selection. But in three examples (AG1315, AG2295, and AG3065), although 83 to 100lo of the Kmr transductants were Tet', the level of Cmr was still about 20%o of the original amplified levels (as seen in the size of colonies on plates with 10 and 20 ,ug of chloramphenicol per ml). Table 4 . The numbers on bars below the figure indicate average P1 cotransducibility (percent) between the connected markers, from the two-factor crosses in Table 4 .
These anomalous chloramphenicol results might suggest that independent mutational events may occur at different levels of chloramphenicol selection in separate experiments. However, the data in Table 6 clearly demonstrate a distinction between high-level Tcr Cmr and low-level Cmr components.
The residual Cmr component could be due to loci such as cmlA and cmlB that might not be (Table 4 and Fig.  1 ). It is difficult to invoke a single locus that elaborates each of these phenotypes, and it is likely-and the merodiploid analyses and reversion tests support this conclusion-that two or more loci are indicated. However, our data suggest that a single locus-that at 34 min-is critical for the expression of Tcr, Cmr and other resistance phenotypes from itself and other alleles.
Our identification of this apparent multiple resistance allele and pleiotropic locus in the major cotransduction gap is interesting, particularly in view of recent suggestions (4) that this region is genetically "silent" either in lacking gene clusters or in containing more "exotic" genes with less detectable mutant phenotypes. The position of the marA locus shortens the major cotransduction gap of 3.2 min by 0.4 min. The stability of TnS in this locus during Pl transduction suggests its usefulness as a new marker in a relatively void region of the K-12 chromosome.
In the accompanying paper (9) we described an energy-dependent efflux system for tetracycline. This efflux was lost upon TnS insertional inactivation, but was recovered upon reversion to Kmn Tet Cml (unpublished results). All lowlevel Tet mutants exhibited tetracycline efflux and therefore presumably contain marA, but all low-level Cml mutants were not Tcr and did not exhibit tetracycline efflux; only first-step Cml mutants that expressed Tcr and all second-step Cml mutants (which expressed coordinate Tcr) contain the marA mutation, as defined by the presence of the efflux system (9) .
We propose that the expression of resistance phenotypes requires a functional marA allele. The marA+ allele exerts partial (or complete) dominance in trans to the marA allele of the host chromosome (Table 2) , but marA+ is nonfunctional-in so far as resistance is concerned-in wild-type strains since the introduction of episomal marA+ alleles into amplified hosts inactivated by marA20::Tn5 does not produce Tcr or Cmr. However, subsequent amplification of these partial diploids proceeds with relative ease due to a marA+-to-marA transition in the F' plasmid while the host chromosome retains the inactivating TnS insertion.
The mechanism of amplification of resistance and its instability when the selective pressure is removed are difficult to explain without additional data. However, it could be speculated that amplification occurs by duplication of one or more mutant alleles as a consequence of tetracycline or chloramphenicol selection.
The amplification process, the attendant multiplicity of resistance phenotypes, and the presence of a tetracycline efflux system suggest two models for the operation of the marA locus. In the first, one might imagine a single regulating allele that is functional in Tet and Cml mutants and dysfunctional or nonfunctional in wild-type strains or TnS-inactivated mutants. The allele also regulates the function of other spatially separated alleles involved in the expression of resistance phenotypes. The second model contains the same features as the first, with the addendum that marA may be one of two or more members of an operon. In this situation one would expect that TnS in AG1025 was probably inserted in the promoter of the operator-proximal gene or in the structural region of a critical regulatory or structural gene. In both models the presence of more than one marA allele cannot be excluded.
